焦点解决团体治疗联合艾司西酞普兰对抑郁障碍患者心理弹性和希望水平的影响

Effect of Resilience and Hope Levels in patients with depressed disorders by solution focused group ther-apy combined with Escitalopram

目的探讨焦点解决团体治疗(Solution Focused Group therapy,SFGT)联合艾司西酞普兰与单一服用艾司西酞普兰对抑郁障碍患者心理弹性和希望水平的影响。方法选取符合《国际疾病分类(第10版)》抑郁障碍诊断标准的84例患者,随机分入联合组和对照组,开展为期8周的治疗。采用心理弹性量表(the Connor-Davidson Resilience Scale,CDRISC)和希望水平量表(Herth Hope Index,HHI)进行效果评价,并使用SPSS 22.0进行数据分析。结果8周治疗结束后,联合组脱落8例,对照组脱落10例,2组在基线时CDRISC、HHI总分及维度分均无差异,治疗4周时、8周时CDRISC、HHI总分及维度分联合组均高于对照组,且具有统计学意义(P<0.05)。结论SFGT联合艾司西酞普兰治疗对抑郁障碍患者心理弹性和希望水平的疗效比单一服用艾司西酞普兰治疗效果更好。

Objective To focus on the difference between solution focused group therapy(SFGT)combined with Escitalopram and only use Escitalopram in the treatment of depression group.Methods 84 patients who met the diagnostic criteria of ICD-10 depression were randomly divided into combined treatment group and simple drug group.The effect was evaluated by the Connor-Davidson Resilience Scale(CDRISC)and Herth Hope Index(HHI).Results There was no difference in the subscales and total scores of CDRISC and HHI between the two groups before treatment.The total scores and subscales scores of CDRISC and HHI were higher than those of the control group at the 4th and 8th week in the course of treatment,and the difference was statistically significant(P<0.05).Conclusion SFGT combined with Ecitalopram is more effective than monotherapy for the level of resilience and hope levels in patients with depressive disorder.